Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Holland-Letz

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic ManagementStefan A Koerber, Gerald Stach, Clemens Kratochwil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2019
<sup>68</sup>Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocolFabian Haupt, Lotte Dijkstra, Ian Alberts, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsAli Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2019
Pathologist-level classification of histopathological melanoma images with deep neural networksAchim Hekler, Jochen Sven Utikal, Alexander H Enk, et al.
Frontiers in Medicine|July 17, 2020
Artificial Intelligence in Skin Cancer Diagnostics: The Patients' PerspectiveTanja B Jutzi, Eva I Krieghoff-Henning, Tim Holland-Letz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
Intraindividual Comparison of <sup>99m</sup>Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand <sup>99m</sup>Tc-MIP-1427 in Patients with Osseous Metastasized Prostate CancerHendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate CancerMaria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
Oncotarget|September 18, 2014
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsIrène Baccelli, Albrecht Stenzinger, Vanessa Vogel, et al.
Cell Reports Methods|April 27, 2022
Biosensor for deconvolution of individual cell fate in response to ion beam irradiationMartin Niklas, Julian Schlegel, Hans Liew, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic ManagementStefan A Koerber, Gerald Stach, Clemens Kratochwil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2019
<sup>68</sup>Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocolFabian Haupt, Lotte Dijkstra, Ian Alberts, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsAli Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2019
Pathologist-level classification of histopathological melanoma images with deep neural networksAchim Hekler, Jochen Sven Utikal, Alexander H Enk, et al.
Frontiers in Medicine|July 17, 2020
Artificial Intelligence in Skin Cancer Diagnostics: The Patients' PerspectiveTanja B Jutzi, Eva I Krieghoff-Henning, Tim Holland-Letz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
Intraindividual Comparison of <sup>99m</sup>Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand <sup>99m</sup>Tc-MIP-1427 in Patients with Osseous Metastasized Prostate CancerHendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate CancerMaria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
Oncotarget|September 18, 2014
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsIrène Baccelli, Albrecht Stenzinger, Vanessa Vogel, et al.
Cell Reports Methods|April 27, 2022
Biosensor for deconvolution of individual cell fate in response to ion beam irradiationMartin Niklas, Julian Schlegel, Hans Liew, et al.
Pageof 12